fda on bpc 157 Peptides in the Limelight: US May Ease Restrictions Several Peptides BPC-157 Before the FDA: Briefing
Description
Personal or family history of auto-immune disease for instance, thyroid disease, vitiligo, type 1 diabetes, Sjogrens disease (dry mouth and other symptoms), Addisons disease
Each injection takes about two minutes
Others maintain the standard dose and inject systemically, allowing the peptide to distribute to both injury sites through circulation
In orthopedics models, BPC-157 consistently speeds tendon and muscle healing, with data pointing to angiogenesis modulation (VEGF) during repair
